Therefore, utilizing such a combined model can enhance the prediction of HIF-1α, which holds potential implications for estimating tumor sensitivity to radiotherapy or targeted therapies, as hypoxia is often associated with treatment resistance. Here, HIF1A is linked to neoplasm.